Cardiorenal Safety Markers With Injectable Glucagon-Like Peptide-1 (GLP-1) Agonists in Type 2 Diabetes: A Network Meta-Analysis.
Saved in:
| Title: | Cardiorenal Safety Markers With Injectable Glucagon-Like Peptide-1 (GLP-1) Agonists in Type 2 Diabetes: A Network Meta-Analysis. |
|---|---|
| Authors: | Rai A; Acute Medical Unit (AMU), Impur Christian Hospital, Mokokchung, IND., Kolli M; Telemedicine, Apollo Hospitals, Chennai, IND., Singh GP; Critical Care Medicine, King's College Hospital NHS Foundation Trust, London, GBR., Rishu; General Internal Medicine, Dudley Group of NHS Foundation Trust, Dudley, GBR., Li Cai CY; General Medicine, Hywel Dda Health Board, Wales, GBR.; Rotational in Medicine, Hywel Dda Health Board, Wales, GBR., Balaji H; Emergency Medicine, Southern Health and Social Care Trust, Armagh, GBR., Pongen B; Emergency Medicine, Bethesda Hospital, Kohima, IND., Joy S; Neurology, Baby Memorial Hospital, Kozhikode, IND., Sai A K S; Emergency Medicine, Baby Memorial Hospital, Thodupuzha, IND. |
| Source: | Cureus [Cureus] 2025 Nov 05; Vol. 17 (11), pp. e96162. Date of Electronic Publication: 2025 Nov 05 (Print Publication: 2025). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Cureus, Inc Country of Publication: United States NLM ID: 101596737 Publication Model: eCollection Cited Medium: Print ISSN: 2168-8184 (Print) Linking ISSN: 21688184 NLM ISO Abbreviation: Cureus Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
